Crystal structures of
The invention provides a crystalline complex containing T. foetus IMPDH in complex with inosine monophosphate (IMP), the complex specified by disclosed atomic coordinates. Also provided are crystalline complexes of containing T. foetus IMPDH with both inosine monophosphate (IMP) and mycophenolic acid, with both xanthosine monophosphate (XMP) and mycophenolic acid, with both xanthosine monophosphate (XMP) and nicotinic adenine dinucleotide (NAD), with ribovirin (1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide, and with both ribovirin and mycophenolic acid, each complex specified by disclosed atomic coordinates. Also provided by the invention are the atomic coordinates for these complexes. Further provided by the invention are methods for identifying modulations of IMPDH that employ the atomic coordinates of the invention.
1. The crystalline complex comprising T. foetus IMPDH in complex with ribavirin monophosphate (1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide monophosphate), having atomic coordinates set forth in Table 7.
2. The crystalline complex comprising T. foetus IMPDH in complex with ribavirin monophosphate and mycophenolic acid, having atomic coordinates set forth in Table 6.